Fenwal Inc-医療機器分野:企業M&A・提携分析

◆英語タイトル:Fenwal Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011723
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Fenwal Inc (Fenwal), a subsidiary of Fresenius Kabi AG is a blood technology company that supports transfusion medicine and cell therapies. The company’s products include amicus separator, blood pack units with whole blood filter, mononuclear cell collection, alyx component collection system, aurora plasmapheresis system, blood-pack units with red cell filter, hospital products and blood and plasma center products. It offers products for use in the practice of transfusion medicine, making life-saving blood therapies. Fenwal also provides services such as data management, customer solutions, production management and forecasting tools. The company serves blood centers, hospital blood banks and plasma collection centers. Fenwal is headquartered in Lake Zurich, Illinois, the US.

Fenwal Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Fenwal Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Fenwal Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Fenwal Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Fenwal Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Fenwal Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Fenwal Inc, Medical Equipment, Deal Details 10
Partnerships 10
HemaTerra Technologies Enters Into Co-Development Agreement With Fenwal 10
Fenwal Enters Into Co-Marketing Agreement With Applied Science 11
Fenwal Enters Into Co-Marketing Agreement With Biolog-id For RFID Blood Tracking System 12
Fenwal Enters Into Co-Marketing Agreement With Genesis BPS 13
Acquisition 14
Fresenius Kabi Completes Acquisition Of Fenwal From TPG Capital And Maverick Capital For US$1.1 Billion 14
Fenwal Inc – Key Competitors 16
Fenwal Inc – Key Employees 17
Fenwal Inc – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Joint Venture 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Fenwal Inc, Medical Equipment, Key Facts 2
Fenwal Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Fenwal Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Fenwal Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Fenwal Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Fenwal Inc, Deals By Market, 2011 to YTD 2017 8
Fenwal Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
HemaTerra Technologies Enters Into Co-Development Agreement With Fenwal 10
Fenwal Enters Into Co-Marketing Agreement With Applied Science 11
Fenwal Enters Into Co-Marketing Agreement With Biolog-id For RFID Blood Tracking System 12
Fenwal Enters Into Co-Marketing Agreement With Genesis BPS 13
Fresenius Kabi Completes Acquisition Of Fenwal From TPG Capital And Maverick Capital For US$1.1 Billion 14
Fenwal Inc, Key Competitors 16
Fenwal Inc, Key Employees 17
Fenwal Inc, Subsidiaries 18
Fenwal Inc, Joint Venture 18

★海外企業調査レポート[Fenwal Inc-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Aslan Pharmaceuticals Pte Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Aslan Pharmaceuticals Pte Ltd (Aslan), a subsidiary of Aslan Pharmaceuticals Ltd is a biotechnology company that offers immuno-oncology agents and targeted therapies. The company’s pipeline products comprise varlitinib, ASLAN002, ASLAN003 and ASLAN004. Its ASLAN002 is a small molecule inhibi …
  • Citius Pharmaceuticals Inc (CTXR):製薬・医療:M&Aディール及び事業提携情報
    Summary Citius Pharmaceuticals Inc (Citius), formerly Trail One Inc is a specialty pharmaceutical company that focuses on the development and commercialization of anti-infective products in adjunct cancer care, and critical care drug products. The company’s proprietary product candidates include Min …
  • Adimab LLC-製薬・医療分野:企業M&A・提携分析
    Summary Adimab LLC (Adimab) is an antibody discovery technology provider that offers antibody discovery and optimization platform. The company discovers antibodies for a range of disease areas including oncology, immunomodulation, neuroscience and pain, inflammation, cardiovascular and metabolic dis …
  • SRF Ltd (SRF):企業の財務・戦略的SWOT分析
    SRF Ltd (SRF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Oxeia Biopharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Oxeia Biopharmaceuticals Inc (Oxeia Biopharmaceuticals) is a clinical stage biotech company that develops drug treatments for mild traumatic brain injury or concussion and underlying neuro-metabolic dysfunction. The company’s lead pipeline candidate includes OXE-103, potent mitochondrial sta …
  • Toto Ltd:企業の戦略・SWOT・財務情報
    Toto Ltd - Strategy, SWOT and Corporate Finance Report Summary Toto Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • InterDigital Inc (IDCC):企業の財務・戦略的SWOT分析
    InterDigital Inc (IDCC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • PipeHawk Plc:企業の戦略・SWOT・財務分析
    PipeHawk Plc - Strategy, SWOT and Corporate Finance Report Summary PipeHawk Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Telecom Plus plc (TEP):企業の財務・戦略的SWOT分析
    Telecom Plus plc (TEP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Toho Holdings Co Ltd (8129):企業の財務・戦略的SWOT分析
    Toho Holdings Co Ltd (8129) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • DaVita Inc (DVA):企業の財務・戦略的SWOT分析
    DaVita Inc (DVA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Yes Bank Wealth Management:企業の戦略・SWOT・財務情報
    Yes Bank Wealth Management - Strategy, SWOT and Corporate Finance Report Summary Yes Bank Wealth Management - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Epcor Utilities Inc:発電所・企業SWOT分析
    Epcor Utilities Inc - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees …
  • Enagas SA (ENG):石油・ガス:M&Aディール及び事業提携情報
    Summary Enagas SA (Enagas) is a midstream company. It develops, operates, and maintains gas infrastructure; and operates and maintains gas networks. The company transports natural gas to distribution points. It is the technical manager of the Spanish gas system. Enagas is the technical manager of th …
  • Scottish Power Ltd:企業の発電所・SWOT分析2018
    Scottish Power Ltd - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees …
  • TripAdvisor Inc:企業の戦略・SWOT・財務分析
    TripAdvisor Inc - Strategy, SWOT and Corporate Finance Report Summary TripAdvisor Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Banco Santander (Brasil) SA:企業のM&A・事業提携・投資動向
    Banco Santander (Brasil) SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Banco Santander (Brasil) SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • AES Gener SA (AESGENER):企業の財務・戦略的SWOT分析
    AES Gener SA (AESGENER) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Dongbu Insurance Co., Ltd.:企業の戦略・SWOT・財務情報
    Dongbu Insurance Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Dongbu Insurance Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Median Technologies SA (ALMDT):企業の財務・戦略的SWOT分析
    Summary Median Technologies SA (Median) is a medical technology company that develops and markets medical imaging solutions. The company offers clinical trials, imaging services for CT, scientific consulting, image and clinical data management, image data processing and site support, managed service …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆